Wei Qiao

11PUBLICATIONS
109CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene and molecular therapyDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|Feb 12, 2026
Ibrutinib with Venetoclax in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: A Phase II Study.

Mahesh Swaminathan, Alessandra Ferrajoli, Philip A Thompson

|Jan 15, 2026
Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma.

Adriana C Gamboa, Kever A Lewis, Laura R Prakash

|Jun 30, 2025
5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Randomized Clinical Trial Protocol.

Brittany C Fields, Timothy E Newhook, Heather A Lillemoe

|Apr 11, 2024
Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression.

Wei-Ying Jen, Koji Sasaki, Sanam Loghavi

|Jan 26, 2024
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML.

Nicholas J Short, Naval Daver, Courtney D Dinardo

Pageof 2

Frequent Collaborators

5 joint publications

Tapan M Kadia

5 joint publications

Gautam Borthakur

5 joint publications

Naval G Daver

4 joint publications

Ghayas C Issa